Latest News about REGN
Recent news which mentions REGN
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
August 20, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
The reflation trade is fading. Here’s what to avoid, and where to seek refuge, in commodities.
August 20, 2021
From MarketWatch
U.S. prepares to administer 100 million booster shots as Biden tells Americans it will ‘help us end the pandemic faster’
August 19, 2021
From MarketWatch
From Benzinga
PreMarket Prep Stock Of The Day: Regeneron
August 18, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
August 18, 2021
From Benzinga
5 Stocks Insiders Are Selling
August 18, 2021
From Benzinga
From Benzinga
JD.com And Tesla Lead The Nasdaq Lower Tuesday
August 17, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
From Benzinga
From Benzinga
From Motley Fool
Regeneron's Antibody Cocktail Authorized for Preventing COVID: Why It's Not a Big Deal for the Stock
August 14, 2021
Tickers
REGN
From Motley Fool
eBay And AMD Lead The QQQ Friday
August 13, 2021
From Benzinga
What Rinvoq's Positive News Means for AbbVie
August 13, 2021
From Motley Fool
FDA expected to authorize an extra COVID-19 dose for people with weak immune systems in the first regulatory OK for a booster shot in the U.S.
August 12, 2021
From MarketWatch
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
August 12, 2021
From Motley Fool
From Benzinga
Tickers
REGN
From Motley Fool
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
August 05, 2021
From Benzinga
What Will the Stock Market Do Today? 3 Big Stories to Watch.
August 05, 2021
From InvestorPlace
Delta, Lambda Covid Variants Still Weighing On Market Despite Positive Earnings Reports
August 05, 2021
From Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
August 05, 2021
From Benzinga
Regeneron Beats Street Estimates Big In Q2 As COVID-19 Antibody Boosts Topline, Cuts FY21 R&D Spend Outlook
August 05, 2021
Tickers
REGN
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.